Table 6 Effect of different treatments on the relative expression of p53 and BCL-2 in the liver
From: Berberine-loaded albumin nanoparticles reverse aflatoxin B1-induced liver hyperplasia
Groups/parameters | P53 | PTEN | H19 | IGF-2 |
|---|---|---|---|---|
Tween control | 1.93* ± 0.013 | 5.20* ± 0.08 | 0.32* ± 0.06 | 1.13* ± 0.06 |
Induction | 0.18* ± 0.03 | 0.11* ± 0.06 | 2.67* ± 0.17 | 3.54* ± 0.058 |
BER treatment | 0.93* ± 0.011 | 2.62* ± 0.028 | 1.64* ± 0.05 | 2.11* ± 0.058 |
BER-BSA NPs treatment | 1.05*& ± 0.03 | 3.47*& ± 0.11 | 0.09*& ± 0.01 | 1.27*& ± 0.07 |